Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to one of its lead programs, OPN-6602, for the treatment of multiple myeloma (MM). OPN-6602 is an oral, small molecule inhibitor of the […]
admin
Selkirk Pharma Introduces ClinFAST to Expedite Fill/Finish for Clinical Trials
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the launch of ClinFAST™, a paradigm-shifting service designed to assist clinical stage biotech and pharma companies with a rapid fill/finish process for clinical trial supplies. […]
Homecare Homebase Highlights Pennant Services’ Success in Integrating Acute and Home-Based Care
Homecare HomebaseSM (HCHB), the leading software provider for home-based care, is showcasing how its platform has helped Pennant Services, a leader in home health and hospice care, to power innovative joint ventures with acute care providers. Leveraging HCHB’s platform, Pennant has achieved seamless integration, enhanced clinical collaboration, and improved patient […]
Midwest Health Purchasers Collaborative Partners with Vida Health to Expand Access to Obesity Specialty Care
As employers face growing challenges in addressing obesity and its related conditions, the Midwest Health Purchasers Collaborative (MHPC), a non-profit employer purchasing organization and arm of the Midwest Business Group on Health, has partnered with Vida Health, a virtual obesity and metabolic center of excellence, to provide employers with cost-effective […]
Spring Health Study Published in JAMA Network Open Demonstrates 1.9x ROI of Employer-Sponsored Behavioral Health Benefits
Spring Health, the leading global mental health solution for employers and health plans, today unveiled data from a peer-reviewed study that validates the return on investment (ROI) of employer-sponsored mental health benefits. The study, published in JAMA Network Open, sets a new benchmark in the behavioral health space, and reveals […]
Alegeus and Empower Forge Partnership to Bring Together Health and Wealth
Alegeus, the market leader in healthcare benefit and payment solutions, today announced it has entered into a major strategic partnership with Empower, a leading provider of retirement and wealth management services. The new partnership coincides with the launch of Empower’s Consumer Directed Health Solutions business and positions the company to […]
Clearway Pain Solutions Expands Reach and Expertise with Acquisition of Eastern Neurodiagnostic Associates
Clearway Pain Solutions, a national leader in comprehensive pain management and neurological care, is pleased to announce its acquisition of Eastern Neurodiagnostic Associates P.C., a distinguished multi-specialty medical practice serving Southern New Jersey. This strategic partnership marks an exciting milestone, combining the strengths of two exceptional organizations to deliver enhanced […]
Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market
Clarivate Plc a leading global provider of transformative intelligence and BioWorld by Clarivate, today published a new e-book, Pulsed field ablation: stunning growth shocks the atrial fibrillation market. The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology’s […]
Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology
Alys Pharmaceuticals, Inc. (“Alys”), an immune-dermatology focused company, today announces that the U.S. Food and Drug Administration (FDA) and Health Canada have cleared the Investigational New Drug (IND) / Clinical Trial Application (CTA) for the study of ALY-101 in patients suffering from Alopecia Areata (AA). The Phase 2a trial will […]
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
Intelligent Bio Solutions Inc.a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced plans for a major upgrade to its Intelligent Fingerprinting Drug Screening System. The system upgrade will support multiple languages spoken across North and South America, Europe, Asia Pacific and the Middle East, making the system […]
